Hodgkin's disease in patients older than 70 years of age: a registry-based analysis

Between 1973 and 1993, 529 patients aged 15 years and over with Hodgkin's disease (HD) were entered into a lymphoma registry. Twenty-eight cases (1 only diagnosed at autopsy) of histologically proven HD in patients aged 70 years or older were identified. The distribution of sex, 'B' symptoms, histology and stage was not significantly different from that of younger patients, except for the fact that there were no patients aged 70 years or older with lymphocyte predominant HD. Nineteen patients were treated radically, 5 patients palliatively and 4 patients received no radiotherapy or chemotherapy. Three of the 14 patients treated with chemotherapy achieved the planned dose intensity. The cause-specific 5-year survival was 75% for patients aged 15-69 years and 28% for patients aged 70 years and over (logrank x(2)=43.7, P<0.00001). The younger and older groups treated with radical intent had complete response rates of 97% and 74%, respectively (logrank x(2)=17.91, P<0.00001) and relapse rates at 5 years of 27% and 56%, respectively (logrank x(2)=4.86, P=0.0275). The main reason for the poorer prognosis of patients aged 70 years and over was the increasing difficulty of chemotherapy delivery associated with advancing age. (C) 1997 Elsevier Science Ltd.